Research Site Introduction:
Retina Research Center (RRC) was founded by Brian Berger, M.D. in 2007 as a free standing research facility. RRC conducts clinical trials evaluating drug therapies and drug delivery devices for a variety of retinal diseases including age-related macular degeneration, diabetic eye disease, retinal vein occlusions, MacTel Type II and uveitis. We also participate in anterior segment studies including dry eyes and glaucoma.
We strive to ensure that every patient is an optimal fit for a particular clinical trial and afforded unique, individualized care. RRC has four clinical trial investigators that participate in our trials: Brian B. Berger, MD, Fuad Makkouk, MD, Stephen B. Whiteside, MD and Byron David Brent, MD. Our clinical research coordinators and photographers are friendly, knowledgeable, certified, and look forward to helping you and your family receive the latest treatments for eye diseases.